(Science Photo Library/Getty Images)
Lack Of Insurance Exposes Blind Spots In Vision Care
As many as 16 million people in the United States have undiagnosed or uncorrected vision problems that could be fixed with eyeglasses, contact lenses or surgery.
Will We Still Be Relevant ‘When We’re 64’?
Older adults often feel invisible as their interactions with younger people dwindle and hardly anyone seems to seek their advice. To make matters worse, studies link loneliness to weaker immune systems and poorer physical health.
Sticker Shock Jolts Oklahoma Patient: $15,076 For Four Tiny Screws
A woman with foot pain was floored by the high cost of titanium screws used in her surgery. “Unless the metal [was] mined on an asteroid, I do not know why it should cost that amount,” she says.
First, Marijuana. Are Magic Mushrooms Next?
Advocates in Oregon and Denver are pushing ballot measures to allow possession of mushrooms containing the hallucinogenic ingredient psilocybin, as new research shows it may be useful in treating depression and anxiety. Supporters of a measure to decriminalize magic mushrooms in California ended their effort late last month.
Trump Vows (Again) To Lower Drug Prices But Skeptics Doubt Much Will Change
President Donald Trump’s much-awaited speech about slashing drug costs was long on rhetoric but short on specifics that will reduce prices.
Why Did Novartis Pay Trump’s Lawyer $1.2 Million? Look At Its Drug Prices
Consumers Brace For Premium Hikes While Lawmakers Grasp At Remedies
Under Trump Proposal, Lawful Immigrants Might Be Inclined To Shun Health Benefits
Best Reads Of The Week With Brianna Labuskes
Living Apart Together: A New Option for Older Adults
For The Babies Of The Opioid Crisis, The Best Care May Be Mom’s Recovery
Listless And Lonely In Puerto Rico, Some Older Storm Survivors Consider Suicide
Podcast: KHN’s ‘What The Health?’ The Politics Of Rising Premiums And Menu Labeling
Midterm Elections Are Shaping Up To Be A Referendum On Trumpism
Pre$cription For Power: The Patient Advocacy Database
Patient advocacy groups campaign to raise awareness of diseases, to fund research and to promote policies favorable to their causes on Capitol Hill and at the Food and Drug Administration. But do they represent patients or Big Pharma? Kaiser Health News has compiled and analyzed disclosures to shed light on the flow of money between the pharmaceutical industry and patient advocacy groups.
Stay informed by signing up for the KHN Morning Briefing and other emails:
